Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica Day

Showing results (91-100 of 102) with videos related to

Pageof 11
Sort By:
Rheumatology International|October 22, 2022
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) surveyLeonardo Santos Hoff, Naveen Ravichandran, Samuel Katsuyuki Shinjo, et al.
Rheumatology (Oxford, England)|September 26, 2024
The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD datasetMarco Fornaro, Vincenzo Venerito, Maria Rosa Pellico, et al.
EMBO Molecular Medicine|May 15, 2024
An immunohistochemical atlas of necroptotic pathway expressionShene Chiou, Aysha H Al-Ani, Yi Pan, et al.
Rheumatology (Oxford, England)|March 24, 2023
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveysKshitij Jagtap, R Naveen, Jessica Day, et al.
Rheumatology (Oxford, England)|March 2, 2024
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD studyLeonardo Santos Hoff, Naveen Ravichandran, Parikshit Sen, et al.
Rheumatology (Oxford, England)|April 21, 2023
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveysNaveen R, Parikshit Sen, Zoltán Griger, et al.
Rheumatology International|June 23, 2023
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD studyBohdana Doskaliuk, Naveen Ravichandran, Parikshit Sen, et al.
International Journal of Rheumatic Diseases|November 16, 2023
Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD studyNimrat Kaur Sandhu, Naveen Ravichandraan, Arvind Nune, et al.
Rheumatology (Oxford, England)|February 3, 2023
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveysParikshit Sen, Naveen R, Nazanin Houshmand, et al.
Rheumatology (Oxford, England)|April 2, 2023
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD studySasha Saadia Ali, Naveen R, Parikshit Sen, et al.
Pageof 11

Showing results (91-100 of 102) with videos related to

Sort By:
Pageof 11
Rheumatology International|October 22, 2022
COVID-19 severity and vaccine breakthrough infections in idiopathic inflammatory myopathies, other systemic autoimmune and inflammatory diseases, and healthy controls: a multicenter cross-sectional study from the COVID-19 Vaccination in Autoimmune Diseases (COVAD) surveyLeonardo Santos Hoff, Naveen Ravichandran, Samuel Katsuyuki Shinjo, et al.
Rheumatology (Oxford, England)|September 26, 2024
The impact of multimorbidity on Quality of Life in inflammatory myopathies: A cluster analysis from the COVAD datasetMarco Fornaro, Vincenzo Venerito, Maria Rosa Pellico, et al.
EMBO Molecular Medicine|May 15, 2024
An immunohistochemical atlas of necroptotic pathway expressionShene Chiou, Aysha H Al-Ani, Yi Pan, et al.
Rheumatology (Oxford, England)|March 24, 2023
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveysKshitij Jagtap, R Naveen, Jessica Day, et al.
Rheumatology (Oxford, England)|March 2, 2024
Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD studyLeonardo Santos Hoff, Naveen Ravichandran, Parikshit Sen, et al.
Rheumatology (Oxford, England)|April 21, 2023
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveysNaveen R, Parikshit Sen, Zoltán Griger, et al.
Rheumatology International|June 23, 2023
Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD studyBohdana Doskaliuk, Naveen Ravichandran, Parikshit Sen, et al.
International Journal of Rheumatic Diseases|November 16, 2023
Flares of autoimmune rheumatic disease following COVID-19 infection: Observations from the COVAD studyNimrat Kaur Sandhu, Naveen Ravichandraan, Arvind Nune, et al.
Rheumatology (Oxford, England)|February 3, 2023
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveysParikshit Sen, Naveen R, Nazanin Houshmand, et al.
Rheumatology (Oxford, England)|April 2, 2023
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD studySasha Saadia Ali, Naveen R, Parikshit Sen, et al.
Pageof 11